Top

Amgen Forced To Suspend Trial Of Promising Cancer Drug

November 20, 2008

Amgen Inc., a unit of Takeda Pharmaceutical Co. has been forced to suspend a late-stage trial of a very promising cancer drug.......Washington (dbTechno) - Amgen Inc., a unit of Takeda Pharmaceutical Co. has been forced to suspend a late-stage trial of a very promising cancer drug.

The experimental drug in question is known as motesanib and was going to be used in combination with other drugs as something that could treat lung cancer.

The other drugs it was designed to work along with include carboplatin, as well as paclitaxel.

Data has shown that those who take the new experimental drug experience higher early mortality rates.

This compared directly to patients who were not on the drug and instead were taking a placebo.

Amgen has immediately pulled the plug and suspended the trial.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists

Comments


All comments are moderated.
If your comment is approved, it will be posted within 24 hours





Breaking News

Antipsychotic Drugs For Alzheimer’s Double Death Risk

Boston (dbTechno) - Researchers have come out and stated that antipsychotic drugs used to treat Alzheimer’s increase... 

January 9, 2009 |

Burger King Says Drop 10 Facebook Friends, Get A Whopper

Washington (dbTechno) - Burger King and Facebook are running a bit of a social experiment as they have started a promotion... 

January 9, 2009 |

Palm Pre Smartphone Aims To Destroy iPhone, Blackberry Storm

Washington (dbTechno) - Palm is generating a great deal of buzz with their new Palm Pre smartphone they have unveiled at... 

January 9, 2009 |

Bottom